Tempo Scan Pacific - Public Comps and Valuation Multiples

Tempo Scan Pacific Overview

About Tempo Scan Pacific

PT Tempo Scan Pacific Tbk operates in the pharmaceutical business in Indonesia. It is engaged in the production of tablet/caplets, effervescent powders, liquid/syrup, cream and ointment, and capsule dosage forms, and markets body care products. It operates through the following segments: The Pharmaceuticals segment, the Consumer Products and Cosmetics segment, and the Distribution Services segment. The company caters to both Indonesian and international markets.

Founded

1970

HQ

Employees

4.5K+

Website

temposcangroup.com

Sectors

Biopharmaceuticals
Drug Development & Therapeutics
Health & Beauty
BioTech

Financials

Last FY Revenue $824M

Last FY EBITDA $140M

EV

$498M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Tempo Scan Pacific Financials

See Tempo Scan Pacific valuation multiples based on analyst estimates

Tempo Scan Pacific P&L

In the most recent fiscal year, Tempo Scan Pacific reported revenue of $824M and EBITDA of $140M.

Tempo Scan Pacific expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Tempo Scan Pacific valuation multiples based on analyst estimates

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$824M	XXX	XXX	XXX
Gross Profit	XXX	$313M	XXX	XXX	XXX
Gross Margin	XXX	38%	XXX	XXX	XXX
EBITDA	XXX	$140M	XXX	XXX	XXX
EBITDA Margin	XXX	17%	XXX	XXX	XXX
EBIT	XXX	$109M	XXX	XXX	XXX
EBIT Margin	XXX	13%	XXX	XXX	XXX
Net Profit	XXX	$87.4M	XXX	XXX	XXX
Net Margin	XXX	11%	XXX	XXX	XXX
Net Debt	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Tempo Scan Pacific including revenue, profitability, and margin analysis across different time periods. In the most recent fiscal year, Tempo Scan Pacific achieved $824M in revenue and $140M in EBITDA.
Financial Metric	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	Analyst estimates available to subscribers	$824M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	Analyst estimates available to subscribers	$313M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	Analyst estimates available to subscribers	37.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	Analyst estimates available to subscribers	$140M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	Analyst estimates available to subscribers	16.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	Analyst estimates available to subscribers	$109M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	Analyst estimates available to subscribers	13.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	Analyst estimates available to subscribers	$87.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	Analyst estimates available to subscribers	10.6% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Tempo Scan Pacific

This financial data table provides comprehensive performance metrics for Tempo Scan Pacific, a company based in Indonesia. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Fiscal Year Performance

In the most recent fiscal year, Tempo Scan Pacific reported $824M in total revenue.
Fiscal year EBITDA was $140M.
The company maintained a gross profit margin of 37.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 16.9%.
Net profit margin reached 10.6% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Tempo Scan Pacific. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Tempo Scan Pacific Stock Performance

Tempo Scan Pacific has current market cap of IDR 11.59T (or $700M), and EV of IDR 8.24T (or $498M).

Market Cap Evolution

Tempo Scan Pacific Stock Data

As of October 17, 2025, Tempo Scan Pacific's stock price is IDR 2570 (or $0).

See Tempo Scan Pacific trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$498M	$700M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Tempo Scan Pacific Valuation Multiples

Tempo Scan Pacific's trades at 0.6x EV/Revenue multiple, and 3.6x EV/EBITDA.

See valuation multiples for Tempo Scan Pacific and 15K+ public comps

Tempo Scan Pacific Financial Valuation Multiples

As of October 17, 2025, Tempo Scan Pacific has market cap of $700M and EV of $498M.

Equity research analysts estimate Tempo Scan Pacific's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Tempo Scan Pacific's P/E ratio is not available.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$700M	XXX	$700M	XXX	XXX	XXX
EV (current)	$498M	XXX	$498M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	0.6x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	3.6x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	4.5x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	8.0x	XXX	XXX	XXX
EV/FCF	n/a	XXX	6.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Tempo Scan Pacific Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Tempo Scan Pacific Margins & Growth Rates

Tempo Scan Pacific's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $45K for the same period.

Tempo Scan Pacific's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Tempo Scan Pacific's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Tempo Scan Pacific and other 15K+ public comps

Tempo Scan Pacific Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	17%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.2M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$45K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	14%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	25%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial